当期报告
TransCode(RNAZ)04-24 04:05
$TransCode(RNAZ)$ 8-K Current report, item 5.08 Accession Number: 0001104659-24-050567 Act: 34 Size: 204 KB 网页链接
简介:TransCode Therapeutics, Inc.于2016年1月11日根据特拉华州法律成立。TransCode是一家生物制药公司,致力于开发和商业化用于治疗转移性疾病的创新药物。TransCode正在为其首次临床研究做准备。该公司的主要治疗候选药物TTX-MC138是一种与氧化铁纳米颗粒缀合的寡核苷酸,旨在通过输注给药以抑制转移性肿瘤细胞存活的能力。如果获得批准,该疗法的目标是实现终生消退和患者长期生存。
今开:0.9003 | 昨收:0.9003 |
最高:0.9003 | 最低:0.89 |
涨停价: | 跌停价: |
总市值:6466436 |
TransCode(RNAZ)04-24 04:05
$TransCode(RNAZ)$ 8-K Current report, item 5.08 Accession Number: 0001104659-24-050567 Act: 34 Size: 204 KB 网页链接
TransCode(RNAZ)06-10 20:55
$TransCode(RNAZ)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001104659-24-069885 Act: 34 Size: 37 KB 网页链接
TransCode(RNAZ)05-16 04:45
$TransCode(RNAZ)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001558370-24-008298 Act: 34 Size: 5 MB 网页链接
TransCode(RNAZ)06-14 20:05
$TransCode(RNAZ)$ 8-K/A [Amend] Current report, item 5.07 Accession Number: 0001104659-24-071514 Act: 34 Size: 219 KB 网页链接
TransCode(RNAZ)05-11 04:55
$TransCode(RNAZ)$ PRE 14A Other preliminary proxy statements Accession Number: 0001104659-24-059966 Act: 34 Size: 1 MB 网页链接
TransCode(RNAZ)06-08 04:05
$TransCode(RNAZ)$ 8-K Current report, item 8.01 Accession Number: 0001104659-24-069605 Act: 34 Size: 198 KB 网页链接
TransCode(RNAZ)06-08 04:05
$TransCode(RNAZ)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001104659-24-069608 Act: 34 Size: 24 KB 网页链接
TransCode(RNAZ)05-11 04:55
$TransCode(RNAZ)$ 8-K Current report, item 3.01 Accession Number: 0001104659-24-059963 Act: 34 Size: 207 KB 网页链接
TransCode(RNAZ)06-22 04:05
$TransCode(RNAZ)$ SC 13D General statement of acquisition of beneficial ownership Accession Number: 0001104659-24-073909 Act: 34 Size: 39 KB 网页链接
TransCode(RNAZ)05-16 05:15
$TransCode(RNAZ)$ 8-K Current report, item 8.01 Accession Number: 0001104659-24-062047 Act: 34 Size: 205 KB 网页链接
不会股票的C2023-09-26 00:29
全都是散户账号的庄$TransCode(RNAZ)$ 2.1的时候想买,想了下算了查看全文
利弗魔尔2023-04-05 20:05
- Just cancelled an offering worth up to $500K
- Received funding from NIH ($816K) to continue TTX-C138 program for a third year
- Results from upcoming first in human clinical trial due soon for TTX-MC138$TransCode(RNAZ)$查看全文
邓观澜2023-02-15 18:54
$TransCode(RNAZ)$ 盘前起飞,临床一期过了,埋伏吃大肉。@春江入海流 @老杨的研究院查看全文
医麦客2022-11-11 07:40
2022年11月11日/医麦客新闻 eMedClub News/--2022年11月9日,致力于使用RNA疗法治疗癌症的公司TransCode Therapeutics公布了其RNAi疗法候选药物TTX-siPDL1治疗胰腺癌的积极临床前结果,目前该公司是唯一一家使用RNAi靶向PD-L1的公司。
TTX-siPDL1将靶向PD-L1的siRNA作为其功能成分,可能触发PD...查看全文
非常时刻资本2021-09-24 02:55
$尚高(TYHT)$ 医疗板块的新星股,在逐步走强壮大。$TransCode(RNAZ)$查看全文
AilisaTom2021-09-23 23:33
蹊之美股生物医药2021-07-22 22:45
Gainers:
Chembio Diagnostics (NASDAQ:CEMI) +159%
NeuroMetrix (NASDAQ:NURO) +107%
Cassava Sciences (NASDAQ:SAVA) +29%
TransCode Therapeutics (NASDAQ:RNAZ) +14%
TRxADE HEALTH (NASDAQ:MEDS) +6%
Losers:
Jupiter Wellness (NASDAQ:JU...查看全文
蹊之美股生物医药2021-07-20 21:05
作者:林出
微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
NRx Pharmaceuticals (NASDAQ:NRXP) +45%
AlliedHealthcare Products (NASDAQ:AHPI) +43%
Cytokinetics (NASDAQ:CYTK) +40%
Aethlon Medical (NASDAQ:AEMD)+31%
Losers:
China SXT P...查看全文
Jjjjll2021-07-10 00:43
$TransCode(RNAZ)$ 赚个200块,盲打策略确实不错,就是经常忘了打查看全文
$TransCode(RNAZ)$ SC 13D General statement of acquisition of beneficial ownership Accession Number: 0001104659-24-073909 Act: 34 Size: 39 KB 网页链接
$TransCode(RNAZ)$ 8-K/A [Amend] Current report, item 5.07 Accession Number: 0001104659-24-071514 Act: 34 Size: 219 KB 网页链接
$TransCode(RNAZ)$ 8-K Current report, item 5.07 Accession Number: 0001104659-24-071337 Act: 34 Size: 211 KB 网页链接
$TransCode(RNAZ)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001104659-24-069885 Act: 34 Size: 37 KB 网页链接
$TransCode(RNAZ)$ 8-K Current report, item 8.01 Accession Number: 0001104659-24-069605 Act: 34 Size: 198 KB 网页链接
$TransCode(RNAZ)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001104659-24-069608 Act: 34 Size: 24 KB 网页链接
$TransCode(RNAZ)$ DEFR14A Revised definitive proxy soliciting materials Accession Number: 0001104659-24-063385 Act: 34 Size: 1 MB 网页链接
$TransCode(RNAZ)$ 8-K Current report, item 8.01 Accession Number: 0001104659-24-062047 Act: 34 Size: 205 KB 网页链接
$TransCode(RNAZ)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001558370-24-008298 Act: 34 Size: 5 MB 网页链接
$TransCode(RNAZ)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001104659-24-060659 Act: 34 Size: 39 KB 网页链接